Fairvalue-Calculator Fairvalue-Calculator
EN DE

Kyung Dong Pharmaceutical Co (011040) Fair Value & Analysis

Healthcare · KR · Market cap 137B KRW

Price4,830 KRW
Fair Value6,187 KRW
Upside+28.1%
Quality95/100
Evidence: Medium Range 4,624 KRW – 7,875 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Kyung Dong Pharmaceutical Co (011040) currently trades at 4,830 KRW, while our model-based Fair Value estimate is 6,187 KRW — implying the stock looks roughly 28.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, antihistamine, CNS, antiobesity, neuropathic, osteoporosis, respiratory, allergy, and arthrifuge categories. The company also provides OTC medicines for pain/inflammation, cardiovascular, hepatic protectors, respiratory, gastrointestinal, calcium agent, antihistamine, antifungal, antibiotic, anti-inflammatory enzyme, dermatologic, antiviral, and contraceptive categories; and APIs and health functional foods, as well as quasi drugs. The company was formerly known as Yuil Trading Company and changed its name to Kyung Dong Pharmaceutical Co., Ltd. in February 1976. Kyung Dong Pharmaceutical Co., L…

Open the full interactive analysis →

Similar stocks

ST Pharm Co (237690) -49% NatureCell Co (007390) -97% Oscotec Inc (039200) -10% DongKook Pharmaceutical Co (086450) +7% Kolon Life Science Inc (102940) -15% Komipharm International Co (041960) -88%

Frequently asked questions

Is Kyung Dong Pharmaceutical Co (011040) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 6,187 KRW versus a price of 4,830 KRW — about +28% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 011040?
Our 21-model fair value for Kyung Dong Pharmaceutical Co is 6,187 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 4,830 KRW.
What is the quality score of 011040?
Kyung Dong Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.